An overview of the clinical development of hepatitis A vaccine: Marco Island, Florida, 3 - 6 February 1994
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago, IL
Univ. of Chicago Press
1995
|
| Schriftenreihe: | The journal of infectious diseases
171 : Supplement 1 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben. - Einzelaufnahme eines Zs.-Bandes |
| Beschreibung: | 77 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010129717 | ||
| 003 | DE-604 | ||
| 005 | 19960213 | ||
| 007 | t | ||
| 008 | 950406s1995 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)32145294 | ||
| 035 | |a (DE-599)BVBBV010129717 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-20 |a DE-12 | ||
| 050 | 0 | |a QR201.H46 | |
| 245 | 1 | 0 | |a An overview of the clinical development of hepatitis A vaccine |b Marco Island, Florida, 3 - 6 February 1994 |c guest ed. F. Blaine Hollinger |
| 264 | 1 | |a Chicago, IL |b Univ. of Chicago Press |c 1995 | |
| 300 | |a 77 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a The journal of infectious diseases |v 171 : Supplement |v 1 | |
| 500 | |a Literaturangaben. - Einzelaufnahme eines Zs.-Bandes | ||
| 650 | 7 | |a Hepatitis-A |2 gtt | |
| 650 | 2 | |a Hepatovirus - Congrès comme sujet | |
| 650 | 2 | |a Hépatite virale A - Prévention et contrôle - Congrès | |
| 650 | 4 | |a Marco Island, Floride - 1994 | |
| 650 | 2 | |a Vaccin antihépatite virale - Congrès comme sujet | |
| 650 | 7 | |a Vaccins |2 gtt | |
| 650 | 4 | |a Hepatitis A virus |x Research | |
| 650 | 4 | |a Vaccines |x Research | |
| 650 | 0 | 7 | |a Hepatitis A |0 (DE-588)4159547-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1994 |z Marco Island |2 gnd-content | |
| 689 | 0 | 0 | |a Hepatitis A |0 (DE-588)4159547-6 |D s |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Hollinger, F. B. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006727268 | ||
Datensatz im Suchindex
| _version_ | 1804124523836997632 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010129717 |
| callnumber-first | Q - Science |
| callnumber-label | QR201 |
| callnumber-raw | QR201.H46 |
| callnumber-search | QR201.H46 |
| callnumber-sort | QR 3201 H46 |
| callnumber-subject | QR - Microbiology |
| ctrlnum | (OCoLC)32145294 (DE-599)BVBBV010129717 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01655nam a2200445 cb4500</leader><controlfield tag="001">BV010129717</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960213 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950406s1995 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32145294</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010129717</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR201.H46</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">An overview of the clinical development of hepatitis A vaccine</subfield><subfield code="b">Marco Island, Florida, 3 - 6 February 1994</subfield><subfield code="c">guest ed. F. Blaine Hollinger</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, IL</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">77 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">The journal of infectious diseases</subfield><subfield code="v">171 : Supplement</subfield><subfield code="v">1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben. - Einzelaufnahme eines Zs.-Bandes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis-A</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hepatovirus - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hépatite virale A - Prévention et contrôle - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marco Island, Floride - 1994</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccin antihépatite virale - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccins</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis A virus</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hepatitis A</subfield><subfield code="0">(DE-588)4159547-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Marco Island</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hepatitis A</subfield><subfield code="0">(DE-588)4159547-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hollinger, F. B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006727268</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1994 Marco Island gnd-content |
| genre_facet | Konferenzschrift 1994 Marco Island |
| id | DE-604.BV010129717 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:47:01Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006727268 |
| oclc_num | 32145294 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-20 DE-12 |
| physical | 77 S. Ill., graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Univ. of Chicago Press |
| record_format | marc |
| series2 | The journal of infectious diseases |
| spelling | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 guest ed. F. Blaine Hollinger Chicago, IL Univ. of Chicago Press 1995 77 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier The journal of infectious diseases 171 : Supplement 1 Literaturangaben. - Einzelaufnahme eines Zs.-Bandes Hepatitis-A gtt Hepatovirus - Congrès comme sujet Hépatite virale A - Prévention et contrôle - Congrès Marco Island, Floride - 1994 Vaccin antihépatite virale - Congrès comme sujet Vaccins gtt Hepatitis A virus Research Vaccines Research Hepatitis A (DE-588)4159547-6 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1994 Marco Island gnd-content Hepatitis A (DE-588)4159547-6 s Impfstoff (DE-588)4026655-2 s DE-604 Hollinger, F. B. Sonstige oth |
| spellingShingle | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 Hepatitis-A gtt Hepatovirus - Congrès comme sujet Hépatite virale A - Prévention et contrôle - Congrès Marco Island, Floride - 1994 Vaccin antihépatite virale - Congrès comme sujet Vaccins gtt Hepatitis A virus Research Vaccines Research Hepatitis A (DE-588)4159547-6 gnd Impfstoff (DE-588)4026655-2 gnd |
| subject_GND | (DE-588)4159547-6 (DE-588)4026655-2 (DE-588)1071861417 |
| title | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 |
| title_auth | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 |
| title_exact_search | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 |
| title_full | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 guest ed. F. Blaine Hollinger |
| title_fullStr | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 guest ed. F. Blaine Hollinger |
| title_full_unstemmed | An overview of the clinical development of hepatitis A vaccine Marco Island, Florida, 3 - 6 February 1994 guest ed. F. Blaine Hollinger |
| title_short | An overview of the clinical development of hepatitis A vaccine |
| title_sort | an overview of the clinical development of hepatitis a vaccine marco island florida 3 6 february 1994 |
| title_sub | Marco Island, Florida, 3 - 6 February 1994 |
| topic | Hepatitis-A gtt Hepatovirus - Congrès comme sujet Hépatite virale A - Prévention et contrôle - Congrès Marco Island, Floride - 1994 Vaccin antihépatite virale - Congrès comme sujet Vaccins gtt Hepatitis A virus Research Vaccines Research Hepatitis A (DE-588)4159547-6 gnd Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Hepatitis-A Hepatovirus - Congrès comme sujet Hépatite virale A - Prévention et contrôle - Congrès Marco Island, Floride - 1994 Vaccin antihépatite virale - Congrès comme sujet Vaccins Hepatitis A virus Research Vaccines Research Hepatitis A Impfstoff Konferenzschrift 1994 Marco Island |
| work_keys_str_mv | AT hollingerfb anoverviewoftheclinicaldevelopmentofhepatitisavaccinemarcoislandflorida36february1994 |